Dopamine in nucleus accumbens: salience modulation in latent inhibition and overshadowing.
Latent inhibition (LI) is demonstrated when non-reinforced pre-exposure to a to-be-conditioned stimulus retards later learning. Learning is similarly retarded in overshadowing, in this case using the relative intensity of competing cues to manipulate associability. Electrolytic/excitotoxic lesions to shell accumbens (NAc) and systemic amphetamine both reliably abolish LI. Here a conditioned emotional response procedure was used to demonstrate LI and overshadowing and to examine the role of dopamine (DA) within NAc. Experiment 1 showed that LI but not overshadowing was abolished by systemic amphetamine (1.0 mg/kg i.p.). In Experiment 2, 6-hydroxydopamine (6-OHDA) was used to lesion DA terminals within NAc: both shell- and core- (plus shell-)lesioned rats showed normal LI and overshadowing. Experiment 3 compared the effects of amphetamine microinjected at shell and core coordinates prior to conditioning: LI, but not overshadowing, was abolished by 10.0 but not 5.0 µg/side amphetamine injected in core but not shell NAc. These results suggest that the abolition of LI produced by NAc shell lesions is not readily reproduced by regionally restricted DA depletion within NAc; core rather than shell NAc mediates amphetamine-induced abolition of LI; overshadowing is modulated by different neural substrates.
Institute of Neuroscience, School of Psychology, University of Nottingham, Nottingham, UK.
A J D
AJ
Nelson
K E
KE
Thur
C A
CA
Marsden
H J
HJ
Cassaday
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D003213:Conditioning, Psychological / Q000187:drug effects*; D004298:Dopamine / Q000032:analysis / Q000502:physiology*; D007266:Inhibition, Psychological; D008297:Male; D009714:Nucleus Accumbens / Q000502:physiology*; D016627:Oxidopamine; D051381:Rats; D017208:Rats, Wistar; D011930:Reaction Time / Q000187:drug effects*
D016627:Oxidopamine; D000661:Amphetamine; D004298:Dopamine
Schizophr Res. 2001 Mar 30;48(2-3):273-89
11295380
Psychopharmacology (Berl). 1992;107(2-3):425-30
1615140
Psychopharmacology (Berl). 1987;91(3):345-51
3104957
Behav Brain Res. 1996 Nov;81(1-2):123-33
8950008
Behav Brain Res. 1997 Oct;88(1):11-25
9401704
Biol Psychiatry. 1982 Jun;17(6):743-56
7104422
Psychopharmacology (Berl). 1993;110(4):479-89
7870920
Pharmacol Biochem Behav. 1988 Aug;30(4):871-8
3227035
Behav Brain Res. 2009 Dec 7;204(2):369-86
19433114
Neuroscience. 1997 Feb;76(3):689-706
9135043
Psychopharmacology (Berl). 1984;83(2):194-9
6431473
Mol Interv. 2005 Feb;5(1):30-41
15734717
J Comp Neurol. 1992 Feb 15;316(3):314-47
1577988
Neuroscience. 2000;101(4):921-30
11113341
Behav Pharmacol. 2003 Jul;14(4):315-22
12838037
Eur J Neurosci. 2008 Jul;28(2):342-52
18702705
Psychopharmacology (Berl). 2002 Jul;162(3):225-31
12122479
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1249-53
15588750
Pharmacol Biochem Behav. 1998 Mar;59(3):557-66
9512057
Science. 2001 Nov 2;294(5544):1024-30
11691979
Psychopharmacology (Berl). 2003 Sep;169(3-4):257-97
12601500
Brain Res. 1987 Mar 17;406(1-2):136-46
3105812
Behav Neurosci. 2010 Dec;124(6):789-99
21133535
Ann N Y Acad Sci. 1999 Jun 29;877:723-7
10415692
J Psychopharmacol. 2008 Mar;22(2):172-81
18208926
Am J Psychiatry. 2003 Jan;160(1):13-23
12505794
Biol Psychiatry. 1982 Mar;17(3):351-61
7082701
Neuroscience. 2001;105(4):863-70
11530224
Neuroscience. 2005;136(4):1049-71
16226842
Behav Brain Res. 1984 Apr;12(1):39-53
6732912
Neuroscience. 2002;111(1):95-109
11955715
Neuroscience. 2000;97(3):469-77
10828530
Psychol Bull. 1990 Nov;108(3):442-61
1980149
Pharmacol Biochem Behav. 1993 Dec;46(4):943-51
8309975
Behav Brain Res. 2002 Dec 2;137(1-2):179-87
12445723
Q J Exp Psychol B. 1994 Aug;47(3):263-91
7972889
J Comp Physiol Psychol. 1959 Aug;52:415-9
14418647
Biol Psychiatry. 1981 Jun;16(6):519-37
7196265
Psychopharmacology (Berl). 1997 Jan;129(2):112-20
9040116
Neurobiol Learn Mem. 1995 Jul;64(1):36-48
7582810
Pharmacol Biochem Behav. 1993 Apr;44(4):751-4
8469686
J Neurosci. 2003 Jul 16;23(15):6295-303
12867514
Neuroscience. 2002;111(2):315-23
11983317
Trends Pharmacol Sci. 2004 Aug;25(8):402-6
15276708
Behav Brain Res. 1997 Oct;88(1):27-34
9401705
Psychopharmacology (Berl). 1994 Jun;115(1-2):185-95
7862894
J Nerv Ment Dis. 1988 Oct;176(10):598-606
2903219
J Psychopharmacol. 1999 Dec;13(4):398-405
10667617
J Psychiatr Res. 2006 Mar;40(2):167-77
15882871